Citius PharmaceuticalsCTXR
13F holders, Q1 2025 (March 31)28holders −2
5new positions
6sold out
$1.49avg. 13F price*
At the end of Q1 2025, 28 institutions reported holding Citius Pharmaceuticals Inc. (CTXR) in their 13F filings, down 2 from Q4 2024. 5 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($384K), Geode Capital Management, LLC ($133K) and BlackRock, Inc. ($108K).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $29K |
| Exits | 6 | $197K |
All 13F filers, Q4 2024 → Q1 2025: 85,107 shares bought and 55,837 shares sold, net +29,270 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Vanguard Group Inc. | 0.00% | No change | 257,631 | $384K |
| Geode Capital Management, LLC | 0.00% | Add +16.7% | 89,275 | $133K |
| BlackRock, Inc. | 0.00% | No change | 72,227 | $108K |
| UBS Group AG | 0.00% | Add +143.8% | 67,215 | $100K |
| Squarepoint Ops LLC | 0.00% | Add +22.8% | 60,983 | $91K |
| State Street Corp. | 0.00% | No change | 23,271 | $35K |
| Northern Trust Corp. | 0.00% | Add +18.8% | 15,173 | $23K |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 0.00% | New | 14,000 | $22K |
| Arkadios Wealth Advisors | 0.00% | No change | 10,000 | $15K |
| IFP Advisors, Inc | 0.00% | No change | 7,083 | $11K |
| Chelsea Counsel Co. | 0.00% | New | 4,626 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -46.3% | 4,410 | $7K |
| Group One Trading LLC | 0.00% | Reduce -30.6% | 3,342 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.6% | 2,268 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,527 | $2K |
| Simplex Trading, LLC | 0.00% | Reduce -43.8% | 966 | $1K |
| Luminist Capital LLC | 0.00% | Add +27.9% | 435 | $522 |
| Murphy & Mullick Capital Management Corp | 0.00% | No change | 160 | $238 |
| Princeton Global Asset Management LLC | 0.00% | No change | 160 | $238 |
| JPMorgan Chase & Co. | 0.00% | Add +9.7% | 136 | $203 |
| Smallwood Wealth Investment Management, LLC | 0.00% | New | 120 | $178 |
| Quent Capital, LLC | 0.00% | No change | 108 | $161 |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.6% | 107 | $159 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 80 | $119 |
| Bank of America Corp. | 0.00% | Add +23.6% | 68 | $101 |
| Morgan Stanley | 0.00% | Reduce -81.1% | 60 | $89 |
| Fairscale Capital, LLC | 0.00% | Reduce -88.5% | 42 | $63 |
| Barclays PLC | 0.00% | New | 29 | $43 |
"% of holder's portfolio" is CTXR's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.